Editorial Archives - International Journal of Molecular and Immuno Oncology

Editorial

International Journal of Molecular and Immuno Oncology

Editorial

Molecular insights into tumor microenvironment and targeted therapies

Radhika A. Vaishnav, Joshua Stephen Kingsly

DOI:10.25259/IJMIO_28_2021

Full text | PDF

p.1-2

International Journal of Molecular and Immuno Oncology

Editorial

Hot race for COVID-19 vaccines – Light at the end of the tunnel just got brighter

Purvish Parikh, Randeep Singh

DOI:10.25259/IJMIO_34_2020

Full text | PDF

p.1-3

International Journal of Molecular and Immuno Oncology

Editorial

Hot race for COVID-19 vaccines – Light at the end of the tunnel just got brighter

Purvish Parikh, Randeep Singh

DOI:10.25259/IJMIO_34_2020

Full text | PDF

p.1-3

Editorial

Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!

H. S. Darling, Alok Gupta

DOI:10.25259/IJMIO_23_2019

Full text | PDF

p.1-7

International Journal of Molecular and Immuno Oncology

Editorial

Nanobyte – Perspectives and milestones in molecular biology and immuno-oncology

Radhika A. Vaishnav

DOI:10.25259/IJMIO-1-2019

Full text | PDF

p.1-2

International Journal of Molecular and Immuno Oncology

Editorial

Changing face of genomics in cancer medicine: Which “avatar” to treat?

Radhika A. Vaishnav

DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20164381

p.1-1

International Journal of Molecular and Immuno Oncology

Editorial

Nanobyte

Radhika A. Vaishnav

DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20180465

p.1-1

Editorial

Nanobytes: Innovative approaches in molecular medicine

Radhika A. Vaishnav, Divyesh G. Mehta

DOI:10.25259/IJMIO_35_2020

Full text | PDF

p.4-5

International Journal of Molecular and Immuno Oncology

Editorial

Nanobyte: Molecular and immuno oncology update

Radhika Vaishnav

DOI:10.25259/IJMIO-14-2019

Full text | PDF

p.29-30

International Journal of Molecular and Immuno Oncology

Editorial

Nanobytes

Radhika A. Vaishnav

DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20172636

p.29-29

International Journal of Molecular and Immuno Oncology

Editorial

Nanobyte

Radhika A. Vaishnav

DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20183224

p.36-36

International Journal of Molecular and Immuno Oncology

Editorial

Important COVID-19 update –New life-threatening syndrome in pediatric patients?

Parikh Purvish, Mehta Prashant, Aggarwal Shyam

DOI:10.25259/IJMIO_16_2020

Full text | PDF

p.42-43

Editorial

Why we should rely only on molecular tests based on Indian data

Purvish M. Parikh, Randeep Singh

DOI:10.25259/IJMIO_13_2020

Full text | PDF

p.44-46

International Journal of Molecular and Immuno Oncology

Editorial

Nanobytes

H. S. Darling

DOI:10.25259/IJMIO_11_2021

Full text | PDF

p.54-55

International Journal of Molecular and Immuno Oncology

Editorial

Misleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding?

Purvish M. Parikh, Satish Bhat, Shweta Bansal

DOI:10.25259/IJMIO_8_2019

Full text | PDF

p.58-60

International Journal of Molecular and Immuno Oncology

Editorial

Nanobytes

Radhika Vaishnav

DOI:10.25259/IJMIO_7_2019

Full text | PDF

p.61-62

International Journal of Molecular and Immuno Oncology

Editorial

If tumor changes the tune, we change the music

Divyesh G. Mehta, Radhika A. Vaishnav

DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20184339

p.67-68

International Journal of Molecular and Immuno Oncology

Editorial

Nanobytes-molecular and immuno-oncology

Radhika Vaishnav, Shruti Morjaria

DOI:10.25259/IJMIO_21_2020

Full text | PDF

p.89-91

International Journal of Molecular and Immuno Oncology

Editorial

Advances in immuno-oncology and precision oncology: Where are we heading?

Akhil Kapoor, Ramya Pragya

DOI:10.25259/IJMIO_19_2021

Full text | PDF

p.109-110

© Copyright 2022 – International Journal of Molecular and Immuno Oncology – All rights reserved.
Published by Scientific Scholar on behalf of Molecular Oncology Society and Immuno Oncology Leadership Network.

ISSN (Print): Awaited
ISSN (Online): 2456-3994